ATE471985T1 - Protease from lucilia sericata und deren verwendung zur wundheilung - Google Patents

Protease from lucilia sericata und deren verwendung zur wundheilung

Info

Publication number: ATE471985T1
Authority: AT; Austria
Prior art keywords: amc; lucilia sericata; proteolytic activity; activity against; protease
Prior art date: 1999-10-22

Application number

AT00969689T

Other languages

English (en)

Inventor

David Idris Pritchard

Original Assignee

Secr Defence

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-22

Filing date

2000-10-20

Publication date

2010-07-15

2000-10-20 Application filed by Secr Defence filed Critical Secr Defence

2010-07-15 Application granted granted Critical

2010-07-15 Publication of ATE471985T1 publication Critical patent/ATE471985T1/de

Links

241000736227 Lucilia sericata Species 0.000 title abstract 2
108091005804 Peptidases Proteins 0.000 title 1
239000004365 Protease Substances 0.000 title 1
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title 1
230000029663 wound healing Effects 0.000 title 1
102000004169 proteins and genes Human genes 0.000 abstract 3
108090000623 proteins and genes Proteins 0.000 abstract 3
230000002797 proteolythic effect Effects 0.000 abstract 3
239000005018 casein Substances 0.000 abstract 2
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 abstract 2
LGKDEBYYRWXEDL-UHFFFAOYSA-N 2-aminobenzenecarboximidamide Chemical compound NC(=N)C1=CC=CC=C1N LGKDEBYYRWXEDL-UHFFFAOYSA-N 0.000 abstract 1
206010052428 Wound Diseases 0.000 abstract 1
208000027418 Wounds and injury Diseases 0.000 abstract 1
239000003001 serine protease inhibitor Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Insects & Arthropods (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Hematology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Biochemistry (AREA)
Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Enzymes And Modification Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

AT00969689T 1999-10-22 2000-10-20 Protease from lucilia sericata und deren verwendung zur wundheilung ATE471985T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9925005.2A GB9925005D0 (en)	1999-10-22	1999-10-22	The treatment of wounds
PCT/GB2000/004034 WO2001031033A2 (en)	1999-10-22	2000-10-20	Protease from lucila sericata and its use in treatment of wounds

Publications (1)

Publication Number	Publication Date
ATE471985T1 true ATE471985T1 (de)	2010-07-15

Family

ID=10863184

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00969689T ATE471985T1 (de)	1999-10-22	2000-10-20	Protease from lucilia sericata und deren verwendung zur wundheilung

Country Status (7)

Country	Link
US (2)	US7144721B1 (de)
EP (1)	EP1222285B1 (de)
AT (1)	ATE471985T1 (de)
AU (1)	AU7934500A (de)
DE (1)	DE60044584D1 (de)
GB (1)	GB9925005D0 (de)
WO (1)	WO2001031033A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE19901134C2 (de) *	1999-01-14	2002-11-21	Wilhelm Fleischmann	Verbandsmaterial
US20080108551A1 (en) *	2006-07-06	2008-05-08	The Secretary Of State For Defence	Treatment of wounds
DE10138303A1 (de) *	2001-08-10	2003-03-06	Aventis Pharma Gmbh	Verwendung von Enzymisolaten aus Fliegenlarven zur Wundbehandlung
GB0127618D0 (en) *	2001-11-17	2002-01-09	Univ Nottingham	"Composition and method for treatment of wounds"
GB0205593D0 (en) *	2002-03-09	2002-04-24	Univ Nottingham	Treatment of surfaces populated by bacteria
DE10342104A1 (de) *	2003-09-10	2005-06-09	Fleischmann, Wilhelm, Dr.med.	Verfahren zur Herstellung eines Mittels zur Wundbehandlung und nach diesem Verfahren hergestelltes Mittel
DE102005061246A1 (de) *	2005-12-20	2007-06-28	Alpha-Biocare Gmbh	Präparate mit niedermolekularen Substanzen aus Dipteren zur Behandlung von Wunden
GB0607495D0 (en) *	2006-04-13	2006-05-24	Secr Defence	Larval enzymes
US20100008898A1 (en) *	2006-05-31	2010-01-14	David Idris Pritchard	Chymotrypsin from lucilia sericata larvae and its use for the treatment of wounds
GB0610697D0 (en) *	2006-05-31	2006-07-12	Secr Defence	Larval enzyme
GB0700946D0 (en) *	2007-01-18	2007-02-28	Uws Ventures Ltd	Antimicrobial composition and a method of controlling contamination and infection using said composition
EP2226382A1 (de) *	2009-03-03	2010-09-08	B.R.A.I.N. Biotechnology Research and Information Network AG	Protease zur Wundbehandlung und Hautpflege
US10513696B2 (en)	2016-05-24	2019-12-24	Hamzeh Alipour	Lucilia sericata collagenase

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0269724A1 (de)	1986-06-17	1988-06-08	Celltech Limited	Verfahren zur herstellung eines proteins
US5352664A (en)	1986-10-31	1994-10-04	Board Of Regents, The University Of Texas System	Thrombin derived polypeptides; compositions and methods for use
US5688768A (en)	1991-02-19	1997-11-18	Cor Therapeutics, Inc.	Recombinant thrombin receptor and related pharmaceuticals
US5892014A (en)	1996-10-30	1999-04-06	The Regents Of The University Of California	DNA encoding a protease-activated receptor 3
AU2672899A (en)	1998-02-27	1999-09-15	Regents Of The University Of California, The	Protease-activated receptor 4 and uses thereof

1999
- 1999-10-22 GB GBGB9925005.2A patent/GB9925005D0/en not_active Ceased
2000
- 2000-10-20 DE DE60044584T patent/DE60044584D1/de not_active Expired - Lifetime
- 2000-10-20 EP EP00969689A patent/EP1222285B1/de not_active Expired - Lifetime
- 2000-10-20 AT AT00969689T patent/ATE471985T1/de not_active IP Right Cessation
- 2000-10-20 AU AU79345/00A patent/AU7934500A/en not_active Abandoned
- 2000-10-20 WO PCT/GB2000/004034 patent/WO2001031033A2/en not_active Ceased
- 2000-10-20 US US10/111,252 patent/US7144721B1/en not_active Expired - Fee Related
2006
- 2006-08-31 US US11/515,156 patent/US20070066538A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE60044584D1 (de)	2010-08-05
AU7934500A (en)	2001-05-08
WO2001031033A3 (en)	2001-09-20
US7144721B1 (en)	2006-12-05
EP1222285A2 (de)	2002-07-17
WO2001031033A2 (en)	2001-05-03
GB9925005D0 (en)	1999-12-22
US20070066538A1 (en)	2007-03-22
EP1222285B1 (de)	2010-06-23

Similar Documents

Publication	Publication Date	Title
ATE471985T1 (de)	2010-07-15	Protease from lucilia sericata und deren verwendung zur wundheilung
DE69826695D1 (de)	2004-11-04	Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen
NZ335981A (en)	2000-04-28	Ketobenzamides as calpain inhibitors
DE69734661D1 (de)	2005-12-22	Foerderung der wundheilung durch chemisch modifizierte tetracycline
DE60027894D1 (de)	2006-06-14	Milchsäurebakterienkombination und deren verwendung zur behandlung und prävention von infektionen und entzündungen
DE69939481D1 (de)	2008-10-16	Methode zur behandlung von diabetes die einen ap2-inhibitor und dazugehörige kombinationen verwendet
ATE357272T1 (de)	2007-04-15	Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten
EP2050750A3 (de)	2009-07-08	Multicyclische Verbindungen und deren Verwendung als Inhibitoren der PARP, VEGFR2 und MLK3 Enzyme
ATE512650T1 (de)	2011-07-15	Hydrogelwundverband und zugehöriges herstellungs- und benutzungsverfahren
ES2191102T3 (es)	2003-09-01	Heterociclos de peptidilo utiles en el tratamiento de las afecciones relacionadas con la trombina.
CA2322502A1 (en)	1999-09-16	Protease inhibitors in absorbent articles
EP1178800A4 (de)	2002-07-31	Verfahren zur Behandlung von Neurodegenerativen Störungen unter Verwendung der Inhibitoren von Aspartyl-Protease
EA200400482A1 (ru)	2004-12-30	Кератиноциты, пригодные для применения в качестве биологически активной субстанции при лечении ран
DE60324777D1 (de)	2009-01-02	Verwendung von il-18-inhibitoren zur behandlung und/oder prävention von peripheren gefässkrankheiten
EP0832100A4 (de)	1998-09-02	Neuartige metalloprotease-inhibitoren, diese enthaltende pharmazeutische zusammensetzungen und anwendungsverfahren
ATE277943T1 (de)	2004-10-15	Trypsininhibitoren
DE60017133D1 (de)	2005-02-03	Naphthochinonderivate und ihre verwendung zur behandlung und kontrolle von tuberkulose
EP0728481A3 (de)	1998-07-08	Verwendun von Chinoxalinen in Kombination mit Protease-Inhibitoren als Arzneimittel zur Behandlung von AIDS und/oder HIV-Infektionen
ATE290393T1 (de)	2005-03-15	Milchsäurebakterien zur behandlung und prophylaxe von giardiasis
DE60334830D1 (de)	2010-12-16	Furin-hemmer zur behandlung von fibrose und narbenbildung
DE59704933D1 (de)	2001-11-22	Verwendung von PHMB zur Behandlung von Tumorerkrankungen
ATE264101T1 (de)	2004-04-15	Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose
DE60123833D1 (de)	2006-11-23	Entwurf und verwendung von verbesserten zink-chelatbildenden peptiden zur regulation von matrix-metalloproteinasen
IL138594A0 (en)	2001-10-31	Use of protease inhibitors for treating skin wounds
EP1330271A4 (de)	2005-11-09	Verwendung von transkriptionsfaktoren zur behandlung von entzündungen und anderen erkrankungen

Legal Events

Date	Code	Title	Description
2010-12-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties